|
|
Grenzacherstrasse 487, PO Box
Basel, 4005 Switzerland
phone:+41 61 6061 111
fax:+41 61 6061 112
|
|
| Symbol |
BSLN |
| Exchange |
SIX |
| Founded |
0 |
| Employees |
|
|
|
| www.basilea.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Anti-bacterials, anti-fungals and dermatology. |
|
| Management |
| Anthony Man, Chief Executive Officer; Ingrid Heinze-Krauss, Chief Technology Officer; Ronald Scott, Chief Financial Officer; Hans Christian Rohde, Chief Commercial Officer; Dr. Laurenz Kellenberger, Chief Scientific Officer |
| |
|
|
|
|
|
|
|
| Keywords |
| antibacterial, antifungal, oncology, dermatology, isavuconazole |
|
|
|
| Description |
|
Basilea has the objective of discovering and developing novel drugs for the treatment of bacterial infections, fungal infections, and skin diseases. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
